학술논문
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients
Document Type
Article
Author
Source
In: Drugs and Therapy Perspectives . (Drugs and Therapy Perspectives, December 2023, 39(12):432-446)
Subject
Language
English
ISSN
11791977
11720360
11720360